Patents

US 11234975 B2: Levorphanol prodrugs and processes for making and using them

Granted
2022-02-01
Filed
2018-04-12 application 16604710
Type
Utility · 34 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The presently described technology provides compositions of one or more of oxoacids, amino acids, polyethylene glycols, and/or vitamin compounds chemically conjugated to levorphanol ((−)-17-methylmorphinan-3-ol) to form novel prodrugs and compositions of levorphanol.

Source: PVGPATDIS, file of 2026-04-10 (ipg220201.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
KEMPHARM, INC. 57 patentsUS company or organizationFour Corners, FLKEMPHARM, INC Form D issuer EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Travis MickleFour Corners, FL83PVGPATDIS, file of 2026-04-10
Sven GuentherCoralville, IA63PVGPATDIS, file of 2026-04-10
Sanjib BeraBlacksburg, VA25PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/485PVGPATDIS, file of 2026-04-10
C07DHeterocyclic compoundsC07D221/28PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-03-13Release of security interest
Release of security interest
ALTER DOMUS (US) LLC signed 2026-03-12ZEVRA THERAPEUTICS, INC. CELEBRATION, FL75080/907PASDL, file of 2026-10-15
2024-04-08Security interest Security interest
Security interest
ZEVRA THERAPEUTICS, INC. signed 2024-04-05ALTER DOMUS (US) LLC CHICAGO, IL67040/637PASDL, file of 2026-10-15
2024-02-23Name change
Change of name
KEMPHARM, INC. signed 2023-02-21ZEVRA THERAPEUTICS, INC. CELEBRATION, FL66664/108PASDL, file of 2026-10-15
2019-12-11Assignment
Assignment of assignor's interest
GUENTHER, SVEN signed 2019-10-22
MICKLE, TRAVIS signed 2019-11-11
BERA, SANJIB signed 2019-11-12
KEMPHARM, INC. CELEBRATION, FL51245/744ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.